Kyle R. Hager

1.1k total citations
13 papers, 739 citations indexed

About

Kyle R. Hager is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology. According to data from OpenAlex, Kyle R. Hager has authored 13 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrinology. Recurrent topics in Kyle R. Hager's work include Cystic Fibrosis Research Advances (6 papers), Gut microbiota and health (6 papers) and Vibrio bacteria research studies (3 papers). Kyle R. Hager is often cited by papers focused on Cystic Fibrosis Research Advances (6 papers), Gut microbiota and health (6 papers) and Vibrio bacteria research studies (3 papers). Kyle R. Hager collaborates with scholars based in United States, Israel and Australia. Kyle R. Hager's co-authors include Samuel I. Miller, Hillary S. Hayden, M. Brittnacher, Christopher E. Pope, Lucas R. Hoffman, Matthew C. Radey, Elhanan Borenstein, Eli J. Weiss, Christopher J. Damman and Susana Matamouros and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

In The Last Decade

Kyle R. Hager

13 papers receiving 735 citations

Peers

Kyle R. Hager
Joseph D. Planer United States
Allan Walker United States
Sihyug Jang United States
Lisa A. Moulton United States
Kate L Bowerman Australia
Joseph D. Planer United States
Kyle R. Hager
Citations per year, relative to Kyle R. Hager Kyle R. Hager (= 1×) peers Joseph D. Planer

Countries citing papers authored by Kyle R. Hager

Since Specialization
Citations

This map shows the geographic impact of Kyle R. Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle R. Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle R. Hager more than expected).

Fields of papers citing papers by Kyle R. Hager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle R. Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle R. Hager. The network helps show where Kyle R. Hager may publish in the future.

Co-authorship network of co-authors of Kyle R. Hager

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle R. Hager. A scholar is included among the top collaborators of Kyle R. Hager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle R. Hager. Kyle R. Hager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Eng, Alexander, Hillary S. Hayden, Christopher E. Pope, et al.. (2021). Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences. BMC Microbiology. 21(1). 247–247. 12 indexed citations
2.
Meeker, Stacey, Naseer Sangwan, M. Brittnacher, et al.. (2020). CFTR dysregulation drives active selection of the gut microbiome. PLoS Pathogens. 16(1). e1008251–e1008251. 59 indexed citations
3.
Hayden, Hillary S., Alexander Eng, Christopher E. Pope, et al.. (2020). Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure. Nature Medicine. 26(2). 215–221. 66 indexed citations
4.
Nelson, Maria T., Christopher E. Pope, Robyn L. Marsh, et al.. (2019). Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles. Cell Reports. 26(8). 2227–2240.e5. 109 indexed citations
5.
Akullian, Adam, Joel M. Montgomery, Grace John‐Stewart, et al.. (2018). Multi-drug resistant non-typhoidal Salmonella associated with invasive disease in western Kenya. PLoS neglected tropical diseases. 12(1). e0006156–e0006156. 27 indexed citations
6.
Matamouros, Susana, Hillary S. Hayden, Kyle R. Hager, et al.. (2018). Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis. Proceedings of the National Academy of Sciences. 115(7). 1605–1610. 35 indexed citations
7.
Manor, Ohad, Roie Levy, Christopher E. Pope, et al.. (2016). Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Scientific Reports. 6(1). 22493–22493. 97 indexed citations
8.
McAllister, Sean M., et al.. (2016). Silica Biomineralization of Calothrix-Dominated Biofacies from Queen's Laundry Hot-Spring, Yellowstone National Park, USA. Frontiers in Environmental Science. 4. 11 indexed citations
10.
Damman, Christopher J., M. Brittnacher, Maria Westerhoff, et al.. (2015). Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. PLoS ONE. 10(8). e0133925–e0133925. 57 indexed citations
11.
Suskind, David L., M. Brittnacher, Ghassan Wahbeh, et al.. (2015). Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohnʼs Disease. Inflammatory Bowel Diseases. 21(3). 556–563. 185 indexed citations
12.
Matamouros, Susana, Kyle R. Hager, & Samuel I. Miller. (2015). HAMP Domain Rotation and Tilting Movements Associated with Signal Transduction in the PhoQ Sensor Kinase. mBio. 6(3). 38 indexed citations
13.
Rohmer, Laurence, Michael Jacobs, M. Brittnacher, et al.. (2014). Genomic analysis of the emergence of 20th century epidemic dysentery. BMC Genomics. 15(1). 355–355. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026